These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 20470896)

  • 1. Lipid-induced up-regulation of human acyl-CoA synthetase 5 promotes hepatocellular apoptosis.
    Reinartz A; Ehling J; Leue A; Liedtke C; Schneider U; Kopitz J; Weiss T; Hellerbrand C; Weiskirchen R; Knüchel R; Gassler N
    Biochim Biophys Acta; 2010 Sep; 1801(9):1025-35. PubMed ID: 20470896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of enterocyte apoptosis by acyl-CoA synthetase 5 splicing.
    Gassler N; Roth W; Funke B; Schneider A; Herzog F; Tischendorf JJ; Grund K; Penzel R; Bravo IG; Mariadason J; Ehemann V; Sykora J; Haas TL; Walczak H; Ganten T; Zentgraf H; Erb P; Alonso A; Autschbach F; Schirmacher P; Knüchel R; Kopitz J
    Gastroenterology; 2007 Aug; 133(2):587-98. PubMed ID: 17681178
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Death receptor 5 signaling promotes hepatocyte lipoapoptosis.
    Cazanave SC; Mott JL; Bronk SF; Werneburg NW; Fingas CD; Meng XW; Finnberg N; El-Deiry WS; Kaufmann SH; Gores GJ
    J Biol Chem; 2011 Nov; 286(45):39336-48. PubMed ID: 21941003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatic long-chain acyl-CoA synthetase 5 mediates fatty acid channeling between anabolic and catabolic pathways.
    Bu SY; Mashek DG
    J Lipid Res; 2010 Nov; 51(11):3270-80. PubMed ID: 20798351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rat long chain acyl-CoA synthetase 5 increases fatty acid uptake and partitioning to cellular triacylglycerol in McArdle-RH7777 cells.
    Mashek DG; McKenzie MA; Van Horn CG; Coleman RA
    J Biol Chem; 2006 Jan; 281(2):945-50. PubMed ID: 16263710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Free fatty acids sensitise hepatocytes to TRAIL mediated cytotoxicity.
    Malhi H; Barreyro FJ; Isomoto H; Bronk SF; Gores GJ
    Gut; 2007 Aug; 56(8):1124-31. PubMed ID: 17470478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptional activation of hepatic ACSL3 and ACSL5 by oncostatin m reduces hypertriglyceridemia through enhanced beta-oxidation.
    Zhou Y; Abidi P; Kim A; Chen W; Huang TT; Kraemer FB; Liu J
    Arterioscler Thromb Vasc Biol; 2007 Oct; 27(10):2198-205. PubMed ID: 17761945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apoptosis in experimental NASH is associated with p53 activation and TRAIL receptor expression.
    Farrell GC; Larter CZ; Hou JY; Zhang RH; Yeh MM; Williams J; dela Pena A; Francisco R; Osvath SR; Brooling J; Teoh N; Sedger LM
    J Gastroenterol Hepatol; 2009 Mar; 24(3):443-52. PubMed ID: 19226377
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Up-regulation of hepatic fatty acid transporters and inhibition/down-regulation of hepatic OCTN2 contribute to olanzapine-induced liver steatosis.
    Jiang T; Zhang Y; Bai M; Li P; Wang W; Chen M; Ma Z; Zeng S; Zhou H; Jiang H
    Toxicol Lett; 2019 Nov; 316():183-193. PubMed ID: 31437515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia/reoxygenation up-regulated the expression of death receptor 5 and enhanced apoptosis in human hepatocyte line.
    Cao L; Li Y; Cheng F; Li S; Long D
    Transplant Proc; 2006 Sep; 38(7):2207-9. PubMed ID: 16980044
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Promotion of glioma cell survival by acyl-CoA synthetase 5 under extracellular acidosis conditions.
    Mashima T; Sato S; Sugimoto Y; Tsuruo T; Seimiya H
    Oncogene; 2009 Jan; 28(1):9-19. PubMed ID: 18806831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Levels of acyl-coenzyme A synthetase 5 in urothelial cells and corresponding neoplasias reflect cellular differentiation.
    Gaisa NT; Reinartz A; Schneider U; Klaus C; Heidenreich A; Jakse G; Kaemmerer E; Klinkhammer BM; Knuechel R; Gassler N
    Histol Histopathol; 2013 Mar; 28(3):353-64. PubMed ID: 23348389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatic lipid partitioning and liver damage in nonalcoholic fatty liver disease: role of stearoyl-CoA desaturase.
    Li ZZ; Berk M; McIntyre TM; Feldstein AE
    J Biol Chem; 2009 Feb; 284(9):5637-44. PubMed ID: 19119140
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TP53 status regulates ACSL5-induced expression of mitochondrial mortalin in enterocytes and colorectal adenocarcinomas.
    Klaus C; Kaemmerer E; Reinartz A; Schneider U; Plum P; Jeon MK; Hose J; Hartmann F; Schnölzer M; Wagner N; Kopitz J; Gassler N
    Cell Tissue Res; 2014 Jul; 357(1):267-78. PubMed ID: 24770931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
    Kan CF; Singh AB; Dong B; Shende VR; Liu J
    Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MacroH2A1 isoforms are associated with epigenetic markers for activation of lipogenic genes in fat-induced steatosis.
    Podrini C; Koffas A; Chokshi S; Vinciguerra M; Lelliott CJ; White JK; Adissu HA; Williams R; Greco A
    FASEB J; 2015 May; 29(5):1676-87. PubMed ID: 25526730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human intestinal acyl-CoA synthetase 5 is sensitive to the inhibitor triacsin C.
    Kaemmerer E; Peuscher A; Reinartz A; Liedtke C; Weiskirchen R; Kopitz J; Gassler N
    World J Gastroenterol; 2011 Nov; 17(44):4883-9. PubMed ID: 22171129
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The type 2 diabetes presumed causal variant within TCF7L2 resides in an element that controls the expression of ACSL5.
    Xia Q; Chesi A; Manduchi E; Johnston BT; Lu S; Leonard ME; Parlin UW; Rappaport EF; Huang P; Wells AD; Blobel GA; Johnson ME; Grant SFA
    Diabetologia; 2016 Nov; 59(11):2360-2368. PubMed ID: 27539148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholestasis increases tumor necrosis factor-related apoptotis-inducing ligand (TRAIL)-R2/DR5 expression and sensitizes the liver to TRAIL-mediated cytotoxicity.
    Higuchi H; Bronk SF; Taniai M; Canbay A; Gores GJ
    J Pharmacol Exp Ther; 2002 Nov; 303(2):461-7. PubMed ID: 12388624
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Steatotic liver allografts up-regulate UCP-2 expression and suffer necrosis in rats.
    Uchino S; Yamaguchi Y; Furuhashi T; Wang FS; Zhang JL; Okabe K; Kihara S; Yamada S; Mori K; Ogawa M
    J Surg Res; 2004 Jul; 120(1):73-82. PubMed ID: 15172192
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.